Postoperative C5 palsy is a well-recognized complication following cervical spine surgery. However, the precise pathophysiology remains debated given its multifactorial nature. We focused on intraoperative arterial blood pressure (IO-MAP) as a representation of systemic hemodynamic alterations during surgery. We hypothesized that IO-MAP changes may influence the incidence of postoperative C5 palsy.
This study aimed to investigate the relationship between IO-MAP changes during cervical spine surgery and the occurrence of C5 palsy.
This was a retrospective single-center cohort study. Surgical records were reviewed to identify all patients undergoing cervical spine surgery at our institution from 2010 to 2022.
Our cohort included 74 patients with cervical spondylotic myelopathy (CSM), ossification of the posterior longitudinal ligament (OPLL), or other cervical pathologies.
Intraoperative hypotension was defined as ≥5 consecutive drops in IO-MAP to <65 mmHg during surgery, which has been associated with adverse postoperative outcomes like myocardial infarction, acute kidney injury, and mortality. The IO-MAP amplitude was calculated as the difference between maximum and minimum IO-MAP values.
Patients were divided into groups with or without C5 palsy (C5 palsy group vs age-matched control group). Demographics, diagnosis, surgical characteristics, and IO-MAP parameters were recorded. Multivariable logistic regression identified independent risk factors for postoperative C5 palsy.
Among 74 patients (mean age 70.5 years; 22 [30%] female), 13 (17.6%) developed postoperative C5 palsy. Age, sex, diagnosis (OPLL 23% vs 18%), spinal fusion rate (54% vs 33%), and intraoperative hypotension incidence (2.5 vs 3.1 episodes per surgery) were comparable between groups (P > 0.05). However, patients with C5 palsy had greater IO-MAP amplitude versus controls (Δ92 vs Δ73 mmHg, P = 0.013). After adjusting for confounders, IO-MAP amplitude remained an independent risk factor for postoperative C5 palsy (odds ratio 1.03, 95% confidence interval 1.00-1.05, P = 0.03). ROC analysis found an IO-MAP amplitude cutoff of Δ67mmHg predicted C5 palsy with 85% sensitivity and 53% specificity (AUC 0.72, 95% CI 0.56-0.87).
Intraoperative MAP amplitude was closely associated with postoperative C5 palsy occurrence. Our findings emphasize the importance of optimal hemodynamic control to mitigate C5 palsy risk. The gap between maximum and minimum IO-MAP values should be maintained below 67 mmHg.
This abstract does not discuss or include any applicable devices or drugs.
Several studies have explored strategies to prevent proximal junctional kyphosis (PJK). Our study introduces a novel strategy to address the unresolved issue of PJK in ASD, utilizing recombinant human bone morphogenetic protein-2 (rhBMP-2).
This study aimed to investigate the preventive effects of upper instrumented vertebrae (UIV) rhBMP-2 injection on PJK and proximal junctional failure (PJF) and to determine whether UIV bone density significantly increases locally.
A retrospective and prospective case-control study.
The sample consists of 154 patients with ASD (adult spine deformity)
Incidence of PJK and PJF and change in the Hounsfield unit of UIV after 1 year of follow-up
All surgeries were performed with instrumentation and fusion from iliac to T10. In the experimental group, consisting of 25 patients with ASD, rhBMP-2 injection was administered to the vertebral body of UIV. To minimize performance bias, the control-1 group included 66 patients who had undergone ASD surgery by the same surgeon in the year preceding the commencement of the study. Control-2 consisted of 63 patients who had undergone ASD surgery by the same surgeon during the year following the end of the study for experimental group. Postoperatively, we evaluated the presence of PJK and PJF, change in the Hounsfield unit (HU) of UIV after 1 year of follow-up. The control-1 group was respectively collected data and the experimental group and control-2 group were prospectively collected data.
When comparing baseline characteristics with control groups, a significant difference was observed only in BMI with control-1 (p=0.006), control-total (control-1 + control-2, p=0.026) having a higher BMI than the study group. In the group that received rhBMP-2 at UIV, there were 3 cases (12.0%) of PJK, whereas the control-1 and control-2 had 26 cases (39.4%, BMI-adjusted p=0.010) and 20 cases (31.7%, BMI-adjusted p=0.078), respectively. In the control-total group (combining control-1 and control-2 groups), there were 46 cases (35.7%, BMI-adjusted p=0.025) of PJK. Regarding HU measurements, the UIV that received rhBMP-2 showed a statistically significant increase compared with the preoperative values one year after surgery (p=0.001).
Injection of rhBMP-2 at the UIV effectively increased trabecular bone density at the UIV, thereby significantly contributing to the prevention of PJK.
This abstract does not discuss or include any applicable devices or drugs.
This abstract has been previously published as part of the ISSLS 2022 proceedings. For full access to the abstract, please visit the following URL: http://issls-2022.m.issls.currinda.com/schedule/session/330/abstract/3098.